Quick Takeaways
- CVI Investments, Inc. filed SCHEDULE 13G for Processa Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (PCSA).
- Disclosed ownership: 9.9%.
- Date of event: 17 Jun 2025.
CVI Investments, Inc. - 17 Jun 2025 SCHEDULE 13G Report for Processa Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (PCSA)
- Filing Manager
- CVI Investments, Inc.
- Reporting Manager
- CVI Investments, Inc.
- Symbol
- PCSA
- Shares outstanding
- 26,899,778 shares
- Disclosed Ownership
- 2,663,078 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 24 Jun 2025, 10:00:35 UTC
- Date of event
- 17 Jun 2025
- Next filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"CVI Investments, Inc. disclosed 9.9% ownership in Processa Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (PCSA) on 17 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 24 Jun 2025, 10:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. | 9.9% | 2,663,078 | 0 | 2,663,078 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc. | |
| Heights Capital Management, Inc. | 9.9% | 2,663,078 | 0 | 2,663,078 | /s/ Sarah Travis | Sarah Travis, Assistant General Counsel and Assistant Secretary |